Obagi Medical Products, Inc. (NASDAQ:OMPI)

CAPS Rating: 4 out of 5

A pharmaceutical company focused on the aesthetic and skin health markets. The Company develops and commercializes prescription-based, topical skin health systems.

Recs

0
Player Avatar technicalalerts (< 20) Submitted: 9/13/2011 1:04:34 AM : Outperform Start Price: $9.85 OMPI Score: +16.18

watchlist

Featured Broker Partners


Advertisement